Patient-Driven Drug Development

In Dien Ho (ed.), Philosophical Issues in Pharmaceutics: Development, Dispensing, and Use. Springer (2017)
  Copy   BIBTEX


Patient-driven drug development is an emerging approach to pharmaceutical research that is forged in rare-disease communities and patient advocacy networks. Patients and their advocates increasingly engage in drug discovery and influence early-stage drug research as clinical trial participants or through compassionate-use programs. Some advocacy groups and patients also influence which therapies are developed by financing promising treatments that otherwise would not secure funding. Though some critics of patient-driven drug development worry about the ethical and scientific implications of this new approach to research, it also has several advantages over the current system. In this essay I argue that patient-driven drug development is morally permissible.



    Upload a copy of this work     Papers currently archived: 92,261

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

Similar books and articles

Five Un‐Easy Pieces of Pharmaceutical Policy Reform.Marc A. Rodwin - 2013 - Journal of Law, Medicine and Ethics 41 (3):581-589.
The concept of placebo.Professor Zbigniew Szawarski - 2004 - Science and Engineering Ethics 10 (1):57-64.


Added to PP

12 (#1,090,149)

6 months
6 (#530,265)

Historical graph of downloads
How can I increase my downloads?

Author's Profile

Jessica Flanigan
University of Richmond

Citations of this work

Revisiting Pharmaceutical Freedom.Jessica Flanigan - 2022 - HEC Forum 34 (3):291-305.

Add more citations

References found in this work

No references found.

Add more references